Abstract
Variability in transplantation benefits may directly affect outcomes of individuals undergoing autologous or allogeneic hematopoietic stem cell transplantation procedures. The Financial Working Group of the National Marrow Donor Program-sponsored System Capacity Initiative addressed the issue of variable benefits and reviewed multiple transplantation benefit packages from both public and private payer organizations. On completion of the review, a consensus was obtained on defining a recipient benefit package that avoids major coverage gaps that could negatively influence patient outcomes. The recommendation was to encourage adoption of these benefits at a national level by payers, benefit brokers/consultants, and sales teams.
Original language | English (US) |
---|---|
Pages (from-to) | 1671-1676 |
Number of pages | 6 |
Journal | Biology of Blood and Marrow Transplantation |
Volume | 20 |
Issue number | 11 |
DOIs | |
State | Published - Nov 1 2014 |
Keywords
- Consensus
- Hematopoietic stem cell transplantation
ASJC Scopus subject areas
- Hematology
- Transplantation